Toronto, Sept.29, 2017 – MEDEC, the national association representing Canada’s Medical Technology Companies, released the following statement from Brian Lewis, President and CEO, in response to the appointment of Karimah Es Sabar as Chair of the Government of Canada’s health/bio-sciences Economic Strategy Table:

“MEDEC congratulates Karimah Es Sabar on her appointment as Chair of the Government of Canada’s health/bio-sciences Economic Strategy Table.

Ms. Es Sabar’s extensive and wide-ranging global experience as an industry leader and as current CEO and partner of a venture capital firm focused on biotechnology and life sciences companies position her extremely well to lead the Table to tangible solutions that will grow this vitally important sector of Canada’s economy, while enhancing health care sustainability and improving patient care in our country and around the world.

We sincerely look forward to engaging with Ms. Es Sabar and the members of the health/bio-sciences table to bring forward opportunities from the perspective of Canada’s medical technology companies.

Thank you to Prime Minister Trudeau, Minister Bains and Minister Petitpas Taylor for recognizing the immense opportunities that are presented by this sector.”

About MEDEC

MEDEC is the national association representing the medical technology industry in Canada. Our members are committed to providing safe and innovative medical technologies that enhance the quality of patient care, improve patient access to health care, and help enable the sustainability of our publicly-funded health care system. The medical technology industry in Canada employs over 35,000 Canadians in approximately 1,500 facilities, and has sales of over $7 billion per annum. We are committed to supporting the growth of a strong and vibrant medical technology industry that contributes to Canada’s innovation economy.

Contact: Gerry Frenette

Executive Director, Public and Member Relations, MEDEC

(416) 620-1915 ext. 227